31 results
8-K
EX-10.2
SLRX
Salarius Pharmaceuticals Inc
22 Feb 24
Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses
5:55pm
excluded, debarred, suspended, or otherwise ineligible to participate in the federal health care programs or in federal procurement or non-procurement … of a criminal offense that falls within the scope of the federal statute providing for mandatory exclusion from participation in federal health care programs
D
SLRX
Salarius Pharmaceuticals Inc
25 May 23
$6.00 mm in equity / options / securities to be acquired, sold $6.00 mm, 1 investor
3:12pm
& Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
D
SLRX
Salarius Pharmaceuticals Inc
5 May 22
$2.33M in options / securities to be acquired, sold $2.33M, 4 investors
12:00am
& Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
8-K
EX-10.1
764ou0663r
13 Jan 22
Salarius Pharmaceuticals Expands Oncology Pipeline Through Strategic Acquisition of Targeted Protein Degradation Portfolio from DeuteRx, LLC
4:05pm
424B4
ck0athc
10 Feb 20
Prospectus supplement with pricing info
6:14am
8-K/A
h5dlp 0t9cikpr8s
18 Sep 19
Index to Financial Statements
4:55pm
424B3
ji8j f9hv27ze378e
29 Apr 19
Prospectus supplement
9:40pm
S-4/A
dd4ds g7k
25 Mar 19
Registration of securities issued in business combination transactions (amended)
9:54pm
8-K
EX-2.1
53gybw8k4q5i
4 Jan 19
Flex Pharma and Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer
9:04am
425
EX-2.1
1zq9mqj9ehas
4 Jan 19
Business combination disclosure
9:02am